Editorial: It is not a wide-open field for incretins – collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitis

Ratziu V, Pais R.
Aliment Pharmacol Ther. 2019 Sep;50(5):611-612. doi: 10.1111/apt.15414.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: